Literature DB >> 26378995

Thrombocytopenia as a marker of outcome in patients with acute exacerbation of chronic obstructive pulmonary disease.

Mohammad Hossein Rahimi-Rad1, Sheida Soltani, Masome Rabieepour, Shagayegh Rahimirad.   

Abstract

INTRODUCTION: Thrombocytopenia (TP) is associated with poor outcome in patients who are critically ill with pneumonia, burns, and H1N1 influenza. To our knowledge, no similar study in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) has been conducted to date. The aim of this study was to determine the impact of platelet count on the outcome of patients with AECOPD.
MATERIAL AND METHODS: Patients admitted to our teaching hospital for AECOPD were divided into two cohorts, those with and without TP. The outcome of all patients was followed.
RESULTS: Of the 200 patients with AECOPD, 55 (27.5%) had TP. Of these, 14 (25.5%) died in the hospital, whereas of the 145 non-TP patents, 11 (7.5%) died (p-value = 0.001). There was a significantly higher transfer rate to the ICU and mechanical ventilation in TP patients. The mean platelet count was significantly lower in patients who died than those who were discharged (161,672 vs. 203,005 cell/μL; p-value = 0.017). There was negative correlation between duration of hospitalization and platelet count.
CONCLUSION: TP was associated with poor outcome in AECOPD. TP could be considered as a marker for the assessment of inflammation and prognosis in AECOPD patients based on its cost-effective features.

Entities:  

Keywords:  acute exacerbation of COPD; mortality; outcome; platelet count; thrombocytopenia

Mesh:

Substances:

Year:  2015        PMID: 26378995     DOI: 10.5603/PiAP.2015.0056

Source DB:  PubMed          Journal:  Pneumonol Alergol Pol        ISSN: 0867-7077


  5 in total

1.  Prognostic marker for severe acute exacerbation of chronic obstructive pulmonary disease: analysis of diffusing capacity of the lung for carbon monoxide (DLCO) and forced expiratory volume in one second (FEV1).

Authors:  Chin Kook Rhee; Kyung Hoon Min; Juwhan Choi; Jae Kyeom Sim; Jee Youn Oh; Young Seok Lee; Gyu Young Hur; Sung Yong Lee; Jae Jeong Shim
Journal:  BMC Pulm Med       Date:  2021-05-06       Impact factor: 3.317

2.  Platelet distribution width as a prognostic factor in patients with COPD - pilot study.

Authors:  Adam J Białas; Claudio Pedone; Wojciech J Piotrowski; Raffaele Antonelli Incalzi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-08-01

3.  Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD.

Authors:  Ashraf Fawzy; Julie A Anderson; Nicholas J Cowans; Courtney Crim; Robert Wise; Julie C Yates; Nadia N Hansel
Journal:  Respir Res       Date:  2019-05-08

4.  Association of Red Cell Index and Adverse Hospitalization Outcomes in Chronic Obstructive Pulmonary Disease Patients with Acute Exacerbation: A Retrospective Cohort Study.

Authors:  Fu-Zhen Yuan; Wei Shui; Yan-Li Xing; Yuan-Yuan Niu; Xin Zhang; Chang-Ran Zhang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-09-15

5.  Serum Biomarkers in Patients with Stable and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Comparative Study.

Authors:  Füsun Şahin; Ayşe Filiz Koşar; Ayşe Feyza Aslan; Burcu Yiğitbaş; Berat Uslu
Journal:  J Med Biochem       Date:  2019-01-22       Impact factor: 3.402

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.